At Last: Eli Lilly Publishes Data for Catastrophic Alzheimer's Trial Post author:Sam Post published:January 24, 2018 Post category:BioPharma Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace You Might Also Like Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials March 4, 2018 Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area January 3, 2018 Axovant's Much-Hyped Alzheimer's Drug Flunks Phase III Test September 25, 2017
